General Announcement::ASX:TLX; Nasdaq:TLX - 1st Patient Dosed in ProstACT Global Randomized Tx Expansion

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
08-Dec-2025 04:45:24
Status
New
Announcement Sub Title
ASX:TLX; Nasdaq:TLX - 1st Patient Dosed in ProstACT Global Randomized Tx Expansion
Announcement Reference
SG251208OTHRL1WG
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
08/12/2025 17:00:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX; Nasdaq:TLX - 1st Patient Dosed in ProstACT Global Randomized Tx Expansion

Attachments

20251208 ProstACT Global Part 2 FPD vFINAL.pdf
Total size =205K